life sciences

The key to capturing a 20-bagger

Michael Frazis
Michael Frazis
Frazis Capital Partners

Phosphagenics - Returns coming from a >$100m investment

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Invitrocue - this Singapore company can predict cancer treatment outcomes

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Actinogen Medical (ASX: ACW) - Breaking the long dry spell in Alzheimer’s treatment

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Kazia Therapeutics - Picking up where Genentech left off

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Orthocell: Growing with CelGro

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Is this the start of the Australian Life Science Boom? The Viralytics/Merck deal is telling you something...

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Suda Pharmaceuticals - emerging drug reformulation champion

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Want to make money in Life Sciences? Back a female CEO

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Patrys - Cell penetrating monoclonal antibody

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research